SCHEMBL19904747

SCHEMBL19904747

CCCCOP(OCCCC)Oc1cccc(Br)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ LTA4H P09960 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ AKR1C2 P52895 1/20 0.37
▸ AKR1C1 Q04828 1/20 0.37
▸ EGFR P00533 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904703 0.82 MGLL (0.40) ALDH1A1MAPTKDM4ELMNALTA4H
SCHEMBL19904727 0.81 MAOB (0.40) MAOBLTA4HCYP1A2CYP2C19TSHR
SCHEMBL4194351 0.80 ALDH1A1 (0.55) MAOBALDH1A1MAPTKMT2AKDM4E
SCHEMBL445915 0.80 LTA4H (0.53) ALDH1A1LMNALTA4HCYP1A2CYP2D6
SCHEMBL19904760 0.78 CETP (0.44) MAPTKDM4ELTA4HCYP1A2CYP2C19
SCHEMBL6244032 0.77 MAOB (0.48) MAOBALDH1A1MAPTKMT2AKDM4E
SCHEMBL430999 0.76 LTA4H (0.53) ALDH1A1LMNALTA4HCYP1A2CYP2D6
SCHEMBL29033057 0.75 LTA4H (0.52) ALDH1A1LMNALTA4HCYP1A2CYP2C19
SCHEMBL2570157 0.75 TSHR (0.62) MAOBALDH1A1MAPTKMT2AKDM4E
SCHEMBL991869 0.75 LTA4H (0.53) ALDH1A1LMNALTA4HTSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097428-B1 BUTYRYLCHOLINESTERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES MGP BIOTECHNOLOGIES INC (US) 2018-02-28 — — EP disclosed
Send feedback